← Back to news

Markets

Latest Zero-Emission Offerings Spark Bullish Views on Garrett Motion (GTX)

Y

H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)’s PKP2 Program

Y

Goodyear (GT) Set to Benefit From Favorable Replacement Tire Market Potential

Y

Aptiv (APTV) Looking at More Realistic Value and Growth Propositions

Y

2026 Labeled as a Transition Year for Mobileye (MBLY)

Y

AutoZone (AZO) Showing Ambition Towards Accelerating Store Growth

Y

Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT)

Y

H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO)

Y

Alphabet Inc.’s Google Adds More Gemini AI Features to the Chrome Browser

Y

Here Is Why TSMC Could Be Investing More In the US?

Y

Alibaba Group Holding’s Robovan Unit Set to Invest in Zelos Technology, WSJ Reports

Y

Analysts Remain Bullish on Advanced Micro Devices Despite Rumours of MI450-Series Chips Behind Schedule

Y

Morgan Stanley Upgrades Johnson & Johnson to Overweight, Increases PT to $262

Y

Cathie Wood Remains Bullish on Broadcom Amid AI and Datacenter Exposure

Y

Are Coins a Safe-Haven Asset? What Experts Say for 2026

Y

‘We live on Social Security and pensions’: I’m in my 70s and my house needs repairs. Do I take out a $50K loan — or sell stocks?

Y

Palantir Earnings Arrive Just as Stock Could Use Some Good News

Y

C3.ai (AI) Stays Central to AI Debate as Capital Intensity Challenges Investor Confidence

Y

1 Under-the-Radar AI Stock With Explosive Growth Potential

Y

H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)’s Carvykti Despite Sales Miss

Y

Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results

Y

Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX)

Y

Baird Updates Intellia Therapeutics, Inc. (NTLA)’s Financial Model Following Nex-Z Clinical Hold Removal

Y

Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo’s Support on Rett Syndrome Program Progress

Y

Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007

Y

Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion

Y

Goldman Sachs Notes VELA-2 Failure, Calls MoonLake Immunotherapeutics (MLTX) a High-Risk Play

Y

uniQure (QURE) Navigates Gene Therapy Development as Investors Weigh Long-Term Potential

Y

ExxonMobil Continues to Prove It's in a League of Its Own

Y

Celcuity (CELC) Draws Investor Attention as Precision Oncology Strategy Advances

Y

Fed Chair Nominee Kevin Warsh Has Called Bitcoin The 'New Gold', Yet BTC Is Down 3%

Y

Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts

Y

Why Pharming, A Top 3% Biotech Stock, Just Took A Double-Digit Beating

Y

Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments

Y

Rosenblatt Highlights Tax Incentives and Sales Execution as Q4 Upside Drivers for Fortinet, Inc. (FTNT)

Y

Amphenol Corporation (APH) Gains Attention After Dual Price Target Raises

Y

William Blair Notes Rambus Inc. (RMBS) Positioned as Top DRAM Memory Supplier

Y

TD Cowen Expects Dynatrace, Inc. (DT) to Deliver Above-Expectations Results

Y

Nextpower Inc. (NXT) Posts “Beat and Raise” Quarter, Supports Higher Valuation

Y

Needham Notes that Semiconductor Equipment Recovery Is Boosting Nova Ltd. (NVMI)

Y

Analysts Cut Profit Predictions Amid Elon Musk's Big Spending Plans, Fewer EV Models

Y

Treasury Yields Mixed Ahead of Labor Data

Y

Prediction: 2026 Will Be the Year of Ethereum (ETH)

Y

Should You Consider Investing in Knight-Swift Transportation Holdings (KNX)?

Y

FMC Corporation (FMC) Fell After Disappointing Results

Y

Skyworks Solutions (SWKS) Traded Down in Q4. Here’s Why

Y

Crypto Investment Products See Record Outflows Amid BTC, ETH Price Slump

Y

Linq raises $20M to enable AI assistants to live within messaging apps

Y

Earnings Beat Lifted Dollar General (DG) in Q4

Y

Should You Buy AMD Before Feb. 3?

Y